Replies to post #229689 on Biotech Values

[DewDiligence]

OPGN shareholders—(belatedly)—approve merger with CURE.AS:

https://www.globenewswire.com/news-release/2020/03/30/2008465/0/en/OpGen-Announces-Shareholder-Approval-for-Business-Combination-with-Curetis.html

CURE.AS shareholders previously approved the deal.

The merger will close in the next few days.